NYSE
OHI
Last Price
US $46.53
KEY FIGURES
MKT CAP
$13.9B
EPS
TTM
$2.87
PEG
TTM
0.22x
P/E
TTM
16.20x
P/S
TTM
10.76x
YIELD
5.78%
GROWTH
Revenue Y/Y
6.07%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $46.53
-31.33%
Default assumptions
EBITDA Multiple
Fair Value
Market $46.53
-71.18%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Omega Healthcare Investors, Inc. cash flow to debt ratio of 20.64% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Omega Healthcare Investors, Inc.'s free cash flow has increased 23.27% from $712.69M last year to $878.55M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Omega Healthcare Investors, Inc.'s debt to equity ratio is 0.75, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial stability - Healthy debt to equity ratio development.
Omega Healthcare Investors, Inc.'s debt has decreased relative to shareholder equity from 1.07 last year to 0.75 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Omega Healthcare Investors, Inc. has a net debt to EBITDA ratio of 3.61x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Omega Healthcare Investors, Inc.'s interest coverage ratio of 3.88 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Omega Healthcare Investors, Inc.'s profit margin has increased (71.90%) in the last year from 38.65% to 66.43%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Omega Healthcare Investors, Inc.'s short-term assets of $2.06G exceed its short-term liabilities of $594.55M
Increasing performance - ROA.
Omega Healthcare Investors, Inc.'s return on assets of 8.55% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Omega Healthcare Investors, Inc.'s return on equity of 16.51%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Omega Healthcare Investors, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Omega Healthcare Investors, Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Omega Healthcare Investors, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Omega Healthcare Investors, Inc. has a free cash flow yield of 6.31%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Omega Healthcare Investors, Inc.'s yearly earnings has increased 45.23% since last year from $406.33M to $590.11M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Omega Healthcare Investors, Inc.'s yearly revenue has increased 13.19% since last year from $1.05G to $1.19G, signaling increasing performance
Increasing performance - ROIC.
ROIC 34.60% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Increasing performance - 3-year revenue CAGR.
Omega Healthcare Investors, Inc.'s 3-year revenue CAGR of 10.91% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Omega Healthcare Investors, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Omega Healthcare Investors, Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 31.95 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Omega Healthcare Investors, Inc. has an earnings yield of 6.17%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Omega Healthcare Investors, Inc. is overvalued relative to its fair value price of 13.41 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Omega Healthcare Investors, Inc. has an EV/EBITDA ratio of 15.51x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Omega Healthcare Investors, Inc. has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Omega Healthcare Investors, Inc. has a price-to-book ratio of 2.45x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Overvalued - P/S ratio.
Omega Healthcare Investors, Inc. has a price-to-sales ratio of 10.76x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
16.51%
Return on equity
ROIC: 34.60%
Valuation History
16.8X
Price to Earnings
EV/EBITDA: 12.4X
Cash flow
Profit margin
10.33%
(FY vs FY)
Cash flow Y/Y
6.77%
(FY vs FY)
Base valuations use default assumptions. Customize in the Valuator.